1. Home
  2. HTFL

as 10-24-2025 3:52pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Nasdaq

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 2.8B IPO Year: 2025
Target Price: $37.00 AVG Volume (30 days): 358.4K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -15.63 EPS Growth: N/A
52 Week Low/High: $26.56 - $41.22 Next Earning Date: 11-12-2025
Revenue: $148,540,000 Revenue Growth: 44.32%
Revenue Growth (this year): 34.51% Revenue Growth (next year): 24.58%

Latest Heartflow Inc. Common Stock News

HTFL Breaking Stock News: Dive into HTFL Ticker-Specific Updates for Smart Investing

All HTFL News

Share on Social Networks: